Key facts
- This page summarizes Gillian Cannon's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Sep 2025, 20:20.
Gillian Cannon - 04 Sep 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)
- Reporting relationship
- Director
- Issuer ticker
- CORT
- Reported as of
- 04 Sep 2025
- Net transaction value
- -$68.91
- SEC form
- 4
- Accepted by SEC
- 08 Sep 2025, 20:20:17 UTC
- Prior SEC filing
- 12 Jun 2025
- Next SEC filing
- 11 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gillian Cannon filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 08 Sep 2025.
Change
- Previous filing in this sequence was filed on 12 Jun 2025.
- Current net transaction value: -$68.91.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001833910
Primary reporting owner
Cannon Gillian
- Relationship
- Director
- Address
- C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
- Signature
- /s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.
- Signature date
- 08 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CORT
transaction
Common Stock
Options Exercise
- Transaction value
- $252,890
- Shares
- +11,000
- Change %
- Price
- $22.99
- Shares after
- 11,000
- Date
- 04 Sep 2025
- Ownership
- Direct
CORT
transaction
Common Stock
Tax liability
- Transaction value
- $252,959
- Shares
- -3,607
- Change %
- -33%
- Price
- $70.13
- Shares after
- 7,393
- Date
- 04 Sep 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CORT
transaction
Derivative
Stock option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -11,000
- Change %
- -18%
- Price
- $0.000000
- Shares after
- 49,000
- Date
- 04 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,000
- Exercise price
- $22.99
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were withheld so the Reporting Person could satisfy the exercise price from a net (cashless) exercise of options.
Footnote F2
Fully exercisable.
SEC remarks
The power of attorney under which this form was signed is on file with the Commission.